COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus

Hormones (Athens). 2023 Mar;22(1):17-18. doi: 10.1007/s42000-022-00419-1. Epub 2022 Nov 11.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19* / prevention & control
  • Diabetes Mellitus, Type 2*
  • Humans
  • mRNA Vaccines

Substances

  • BNT162 Vaccine